[HTML][HTML] Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy

CY Zhang, S Liu, M Yang - World Journal of Hepatology, 2023 - ncbi.nlm.nih.gov
Chronic liver disease (CLD) is a continuous process that causes a reduction of liver function
lasting more than six months. CLD includes alcoholic liver disease (ALD), non-alcoholic fatty …

[HTML][HTML] What's new in the treatment of non-alcoholic fatty liver disease (NAFLD)

M Kosmalski, R Frankowski, S Ziółkowska… - Journal of Clinical …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a serious health problem due to its high
incidence and consequences. In view of the existing controversies, new therapeutic options …

[HTML][HTML] Chios mastiha essential oil exhibits antihypertensive, hypolipidemic and anti-obesity effects in metabolically unhealthy adults-a randomized controlled trial

A Gioxari, C Amerikanou, E Valsamidou… - Pharmacological …, 2023 - Elsevier
The essential oil of the resinous exudate from Pistacia lentiscus of Chios namely Chios
Mastiha Essential Oil (CMEO), is a natural volatile oil rich in monoterpenes α-pinene, β …

[HTML][HTML] The role of plant-derived natural products in the management of inflammatory bowel disease—what is the clinical evidence so far?

MM Davila, E Papada - Life, 2023 - mdpi.com
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), are a major healthcare challenge worldwide. Disturbances in the immune system and …

Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio

A Saviano, F Raucci, GM Casillo, AA Mansour… - Pharmacological …, 2022 - Elsevier
In the context of inflammation and immunity, there are fragmented and observational studies
relating to the pharmacological activity of Mangifera indica L. and its main active component …

[HTML][HTML] Impact of the exposome on the epigenome in inflammatory bowel disease patients and animal models

S Vieujean, B Caron, V Haghnejad… - International Journal of …, 2022 - mdpi.com
Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal
tract that encompass two main phenotypes, namely Crohn's disease and ulcerative colitis …

[HTML][HTML] Living, Heat-Killed Limosilactobacillus mucosae and Its Cell-Free Supernatant Differentially Regulate Colonic Serotonin Receptors and Immune Response in …

Z Sun, S Huang, X Yan, X Zhang, Y Hao, L Jiang, Z Dai - Nutrients, 2024 - mdpi.com
Lactobacillus species have been shown to alleviate gut inflammation and oxidative stress.
However, the effect of different lactobacilli components on gut inflammation has not been …

[HTML][HTML] Type 2 diabetes mellitus, non-alcoholic fatty liver disease, and metabolic repercussions: the vicious cycle and its interplay with inflammation

R Frankowski, M Kobierecki, A Wittczak… - International Journal of …, 2023 - mdpi.com
The prevalence of metabolic-related disorders, such as non-alcoholic fatty liver disease
(NAFLD) and type 2 diabetes mellitus (DM2), has been increasing. Therefore, developing …

Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review

MI Kan Changez, M Mubeen, M Zehra… - Journal of …, 2023 - journals.sagepub.com
Non-alcoholic fatty liver disease (NAFLD) is a prevalent liver condition that affects people
who do not overconsume alcohol. Uncertainties exist over how microRNAs (miRNAs) in the …

[HTML][HTML] Sialagogic Effects Through Olfactory Stimulation with Mastic Resin and α-pinene Volatiles in vivo

M Faruque, K Nazmi, A van Splunter, ML Laine… - Biomedicine & …, 2023 - Elsevier
Background Xerostomia, often associated with decreased saliva quality, poses challenges
due to limited treatment efficacy. This study aimed to investigate alternative approaches to …